| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO
1 company
Oliveto Joseph is a President and CEO at MIST. Recent filings cover 0 purchases and 5 sales. Those positions are worth an estimated $1.0M at current prices.
Our model assigns Oliveto Joseph a middling insider score of 59/100, based on 3 past trades. On a 3-month view, 100.0% of the rated trades came out ahead, averaging +23.9% over three months.
Oliveto Joseph's largest disclosed position is in MIST as President and CEO, worth about $1.0M. The recent filings there lean toward selling, a net 247,577 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | MIST Milestone Pharmaceuticals Inc. | President and CEO | Sell10b5-1 | 36,500 | $2.26 | $82,490.00 | -7.6% | -39.2% | - | |
| Jan 26, 2026 | MIST Milestone Pharmaceuticals Inc. | President and CEO | Sale+OE | 167,577 | $2.24 | $375,314.67 | -25.8% | -4.1% | - | |
| Jan 8, 2026 | MIST Milestone Pharmaceuticals Inc. | President and CEO | Sell10b5-1 | 43,500 | $2.25 | $97,875.00 | -12.5% | -18.7% | - |